Established in March 2022, the MSSG coordinates urgent actions within the EU to manage medicine supply issues and issues related to the quality, safety and efficacy.
The group, along with its working party, says it has been closely monitoring the situation since November and engaging with ‘key players’ in the supply chain of the antibiotic amoxicillin to agree on possible mitigating measures, such as increasing manufacturing capacity…
